221 results on '"Giannantoni, A"'
Search Results
2. Comparison between the liverpool and the siroky nomograms in the analysis uroflowmetry of young, healthy males
3. Urodynamic findings and functional outcomes after laparoscopic sacrocolpopexy and Trocarless Transvaginal Mesh System for symptomatic pelvic organ prolapse: Two surgical techniques compared
4. Comparison between the liverpool and the siroky nomograms in the analysis uroflowmetry of young, healthy males
5. Intravesical adjuvant electromotive mitomycin-C in patients with primary intermediate-risk urothelial non-muscle invasive bladder cancer: A randomized controlled trial
6. Bladder and bowel dysfunction in patients affected by autism spectrum disorders
7. The role of post-void residual urine in healthy young volunteers
8. Urodynamic findings and functional outcomes after laparoscopic sacrocolpopexy and Trocarless Transvaginal Mesh System for symptomatic pelvic organ prolapse: Two surgical techniques compared
9. The splicing factor PTBP1 promotes expression of oncogenic splice variants and predicts poor prognosis in patients with non-muscle invasive bladder cancer
10. Palmitoylethanolamide/polydatin as add-on therapy in pain resistant patients with interstitial cystitis/bladder painful syndrome
11. Changes in vesico-sphincter function after surgery for pelvic organ prolapse
12. Characterization of whole body pain in patients with interstitial cystitis/ bladder painful syndrome: Relationships between pain sites, urinary symptoms and non-urologic associated syndromes
13. Clinical outcomes of second-line treatments cycling in refractory wet overactive bladder patients before switching to a third-line therapy: A real world observational study
14. The role of post-void residual urine in healthy young volunteers
15. The splicing factor PTBP1 promotes expression of oncogenic splice variants and predicts poor prognosis in patients with non-muscle invasive bladder cancer
16. Intravesical adjuvant electromotive mitomycin-C in patients with primary intermediate-risk urothelial non-muscle invasive bladder cancer: A randomized controlled trial
17. Palmitoylethanolamide/polydatin as add-on therapy in pain resistant patients with interstitial cystitis/bladder painful syndrome
18. Characterization of whole body pain in patients with interstitial cystitis/ bladder painful syndrome: Relationships between pain sites, urinary symptoms and non-urologic associated syndromes
19. Changes in vesico-sphincter function after surgery for pelvic organ prolapse
20. The impact of mirabegron on sexual function in women with overactive bladder
21. Clinical outcomes of second-line treatments cycling in refractory wet overactive bladder patients before switching to a third-line therapy: A real world observational study
22. Relationships between lower urinary tract symptoms and associated clinical features in patients with Parkinson’s disease
23. Comparison between tadalafil 5 mg vs. Serenoa repens/selenium/lycopene for the treatment of benign prostatic lower urinary tract symptoms secondary to benign prostatic hyperplasia. A phase IV, randomized, multicenter, non-inferiority clinical study. SPRITE study
24. The impact of mirabegron on sexual function in women with overactive bladder
25. Relationships between lower urinary tract symptoms and associated clinical features in patients with Parkinson’s disease
26. The use of mirabegron in the treatment of overactive bladder in patients affected by Parkinson’s disease
27. Changes in vesico-sphincter function after surgery for pelvic organ prolapse
28. Comparison between tadalafil 5 mg vs. Serenoa repens/selenium/lycopene for the treatment of benign prostatic lower urinary tract symptoms secondary to benign prostatic hyperplasia. A phase IV, randomized, multicenter, non-inferiority clinical study. SPRITE study
29. Quetiapine fumarate extended release in the treatment of bladder painful syndrome with nonurological associated conditions: An exploratory study
30. SC336 - The splicing factor PTBP1 promotes expression of oncogenic splice variants and predicts poor prognosis in patients with non-muscle invasive bladder cancer
31. SC283 - The role of post-void residual urine in healthy young volunteers
32. SC289 - Bladder and bowel dysfunction in patients affected by autism spectrum disorders
33. SC282 - Comparison between the liverpool and the siroky nomograms in the analysis uroflowmetry of young, healthy males
34. SC153 - Intravesical adjuvant electromotive mitomycin-C in patients with primary intermediate-risk urothelial non-muscle invasive bladder cancer: A randomized controlled trial
35. SC32 - Urodynamic findings and functional outcomes after laparoscopic sacrocolpopexy and Trocarless Transvaginal Mesh System for symptomatic pelvic organ prolapse: Two surgical techniques compared
36. PT224 - Palmitoylethanolamide/polydatin as add-on therapy in pain resistant patients with interstitial cystitis/bladder painful syndrome
37. The use of mirabegron in the treatment of overactive bladder in patients affected by Parkinson’s disease
38. Quetiapine fumarate extended release in the treatment of bladder painful syndrome with nonurological associated conditions: An exploratory study
39. 534 Enuresis and urinary infections in childhood: Bad “news” for young women?
40. 653 Urinary and sexual dysfunction in patients affected by Parkinson's disease
41. 1094 - Clinical outcomes of second-line treatments cycling in refractory wet overactive bladder patients before switching to a third-line therapy: A real world observational study
42. 340 - Relationships between lower urinary tract symptoms and associated clinical features in patients with Parkinson’s disease
43. 534 Enuresis and urinary infections in childhood: Bad 'news' for young women?
44. 653 Urinary and sexual dysfunction in patients affected by Parkinson's disease
45. 67 Abdominal versus laparoscopic sacrocolpopexy: A randomized controlled trial
46. 945 Is intravesical BCG alone still the only truly effective intravesical therapy for high risk nonmuscle invasive bladder cancer?
47. 1094 Changes in the Hoffmann reflex during bladder filling provide clues to the pathophysiology of bladder dysfunction in patients with multiple sclerosis
48. 161 Long-term results of repeated onabotulinumtoxin- A intradetrusor injections for refractory overactive bladder
49. 535 - Comparison between tadalafil 5 mg vs. Serenoa repens/selenium/lycopene for the treatment of benign prostatic lower urinary tract symptoms secondary to benign prostatic hyperplasia. A phase IV, randomized, multicenter, non-inferiority clinical study. SPRITE study
50. 425 - Quetiapine fumarate extended release in the treatment of bladder painful syndrome with nonurological associated conditions: An exploratory study
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.